[
The Herald | HeraldOnline.com](http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVCg8UqhvY3WtA0TLbuXmIB-8ZBw&url=http://www.heraldonline.com/2012/10/12/4332618/genzyme-presents-second-phase.html)
[**Sanofi: Study Shows Aubagio Reduces Patient Relapses**](http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHpozhd18mtj4tK1B7cJztj8L5rrQ&url=http://www.foxbusiness.com/news/2012/10/12/sanofi-study-shows-aubagio-reduces-patient-relapses/)
**Fox Business**
FR) said Friday a study shows its multiple sclerosis treatment teriflunomide, recently approved by the U.S. Food and Drug Administration, reduced relapse rates and **disability** in patients compared with those taking a placebo. The drug, sold under the **...**
[Genzyme Presents Second Phase III Study of Once-daily Oral AUBAGIO **...**](http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHVCg8UqhvY3WtA0TLbuXmIB-8ZBw&url=http://www.heraldonline.com/2012/10/12/4332618/genzyme-presents-second-phase.html)The Herald | HeraldOnline.com
[**all 27 news articles _place_holder;»**](http://news.google.com/news/more?ncl=dUqsKlMjZ-Jto_MRiOUAZrQs1_7LM&ned=us)
URL: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHpozhd18mtj4tK1B7cJztj8L5rrQ&url=http://www.foxbusiness.com/news/2012/10/12/sanofi-study-shows-aubagio-reduces-patient-relapses/
No comments:
Post a Comment